Placebo B

DRUG8 trials

Conditions

Adenomatous Polyposis ColiAlcohol Withdrawal SyndromeDepressionDiabetes Mellitus, Type 1DigestiveGastrointestinal HealthHealthyNonalcoholic Steatohepatitis

Phase 1

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

CompletedNCT04389775

Sciwind Biosciences APAC CO Pty. Ltd.Nonalcoholic Steatohepatitis, Obesity, Type 2 Diabetes Mellitus

Start: 2020-03-29End: 2021-09-29Updated: 2021-10-28

Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

RecruitingNCT07634770

Sam Chun Dang Pharm. Co. Ltd.Diabetes Mellitus, Type 1

Start: 2026-05-29End: 2026-10-01Target: 16Updated: 2026-06-09

A study assessing the safety, tolerability, pharmacokinetics and efficacy of single and multiple doses of NNC0638-0355 in participants with overweight or obesity

Not yet recruitingCTIS2026-526797-16-00

Novo Nordisk A/SObesity and overweight

Target: 170Updated: 2026-09-14

Phase 2

A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients

CompletedNCT01187901

University of UtahAdenomatous Polyposis Coli

Start: 2010-04-30End: 2014-07-31Updated: 2016-06-17

Phase 4

Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine

WithdrawnNCT03788889

Santa Barbara Cottage HospitalAlcohol Withdrawal Syndrome

Start: 2019-04-12End: 2019-04-12Updated: 2019-09-19

Unknown Phase

Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.

WithdrawnNCT02223299

John D. Dingell VA Medical CenterDepression

Start: 2015-11-30End: 2015-11-30Updated: 2020-02-21

Glutamate Supplementation in Young Men

CompletedNCT03425578

University of WaterlooHealthy

Start: 2018-03-19End: 2018-10-02Updated: 2019-06-12

Efficacy of Two Enzyme Cocktails in Healthy Adults

TerminatedNCT06710392

The Archer-Daniels-Midland CompanyDigestive, Gastrointestinal Health

Start: 2025-05-29End: 2026-02-28Updated: 2026-05-12

Related Papers

Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog.

2023-06-2427 citations

Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis

Gut2022-05-3020 citations

Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis

JAMA Oncology2018-02-0877 citations

Abstract LB-074: Regression of duodenal neoplasia in familial adenomatous polyposis patients using COX and EGFR inhibition: A randomized placebo-controlled trial

Cancer Research2016-07-15